Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 5NIH 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 2Other hematologic neoplasm 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Leukemia 1

Interventions

Cytarabine 83Methotrexate 59Cyclophosphamide 58Vincristine 47Daunorubicin 46Prednisone 33Mercaptopurine 33Asparaginase 33Dexamethasone 31Doxorubicin 29Gene Expression Profiling 27Etoposide 27pegaspargase 25Radiotherapy 25Filgrastim 25Thioguanine 24Leucovorin 24Flow Cytometry 23merphos 22Hydrocortisone 20Calcium Dobesilate 20Specimen Handling 18Microarray Analysis 16Idarubicin 16Granulocyte Colony-Stimulating Factor 15Peripheral Blood Stem Cell Transplantation 14Busulfan 14Polymerase Chain Reaction 13Mitoxantrone 13Gemtuzumab 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Trimethoprim, Sulfamethoxazole Drug Combination × Other hematologic neoplasm × Clear all
NCT00109837 2015-03-25

S0333 Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

SWOG Cancer Research Network

Phase 2 Completed
79 enrolled 6 charts
LymphoidOther hematologic neoplasm

Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡